Evidence map›Paper›PMID 25865874›Full record

ArticleNature communications2015

A fungal protease allergen provokes airway hyper-responsiveness in asthma.

Nariman A Balenga, Michael Klichinsky, Zhihui Xie, Eunice C Chan, Ming Zhao, Joseph Jude, Michel Laviolette, Reynold A Panettieri, Kirk M Druey

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 125 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Molecular Study from the Signaling Pathways of Four PotentialInternational journal of molecular sciences · 2025
    Article
  7. Indoor and Outdoor Fungal Allergens and Impacts on Respiratory Allergic Disease.The journal of allergy and clinical immunology. In practice · 2025
    Review
  8. Article
  9. Bronchomotor tone imbalance evokes airway hyperresponsiveness.Expert review of respiratory medicine · 2024
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Aspergillus and the Lung.Seminars in respiratory and critical care medicine · 2024
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Immunity to fungi in the lung.Seminars in immunology · 2023
    Review

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Nariman A BalengaMolecular Signal Transduction Section, Laboratory of Allergic Diseases, NIAID/NIH, 50 South Drive Room 4154, Bethesda, Maryland 20892-8305, USA.
Michael KlichinskyPulmonary, Allergy and Critical Care Division, Airways Biology Initiative, University of Pennsylvania, 125 South 31st Street, Philadelphia, Pennsylvania 19104-3413, USA.
Zhihui XieMolecular Signal Transduction Section, Laboratory of Allergic Diseases, NIAID/NIH, 50 South Drive Room 4154, Bethesda, Maryland 20892-8305, USA.
Eunice C ChanMolecular Signal Transduction Section, Laboratory of Allergic Diseases, NIAID/NIH, 50 South Drive Room 4154, Bethesda, Maryland 20892-8305, USA.
Ming ZhaoProtein Chemistry, Research Technologies Branch, Twinbrook I, 5640 Fishers Lane Room 1012 NIAID/NIH, Rockville, Maryland 20852-1737, USA.
Joseph JudePulmonary, Allergy and Critical Care Division, Airways Biology Initiative, University of Pennsylvania, 125 South 31st Street, Philadelphia, Pennsylvania 19104-3413, USA.
Michel LavioletteInstitut universitaire de cardiologie et pneumologie de Québec (Laval University), Département multidisciplinaire de pneumologie et de chirurgie thoracique de l'IUCPQ, L35312725, chemin Sainte-Foy, Québec, Canada G1V 4G5.
Reynold A PanettieriPulmonary, Allergy and Critical Care Division, Airways Biology Initiative, University of Pennsylvania, 125 South 31st Street, Philadelphia, Pennsylvania 19104-3413, USA.
Kirk M DrueyMolecular Signal Transduction Section, Laboratory of Allergic Diseases, NIAID/NIH, 50 South Drive Room 4154, Bethesda, Maryland 20892-8305, USA.
National Institutes of Health · USPulmonary and Allergy Associates · USInstitut universitaire de cardiologie et de pneumologie de Québec · CAProtein Express (United States) · US

Funding

Translational Research Support CoreP30ES013508 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI Trevor M Penning · 2006 to 2026
$35.3M
Project 4 - OGR1- and TSPO- dependent mechanisms mediated by benzodiazepines affecting ASM contractionP01HL114471 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI LIGGETT, STEPHEN B · 2013 to 2023
$23.9M
Regulation of Normal and Asthmatic Lung Function by G-Protein-Coupled ReceptorsZIAAI000939 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DRUEY, KIRK M · 2009 to 2025
$7.3M
Translational Research Training Program in Environmental Health SciencesT32ES019851 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI Kara A Bernstein, Trevor M Penning · 2012 to 2026
$6.0M
Regulation of Normal and Asthmatic Lung Function by G-Protein-Coupled ReceptorsZ01AI000939 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI DRUEY, KIRK M · 2004 to 2008
$832k
Intramural NIH HHS Z01 AI000939NHLBI NIH HHS P01 HL114471NHLBI NIH HHS P01-HL114471NIEHS NIH HHS P30 ES013508NIEHS NIH HHS P30-ES013508NIEHS NIH HHS T32 ES019851
6 · The paper itself

Abstract

Asthma, a common disorder that affects >250 million people worldwide, is defined by exaggerated bronchoconstriction to inflammatory mediators including acetylcholine (ACh), bradykinin and histamine-also termed airway hyper-responsiveness. Nearly 10% of people with asthma have severe, treatment-resistant disease, which is frequently associated with immunoglobulin-E sensitization to ubiquitous fungi, typically Aspergillus fumigatus (Af). Here we show that a major Af allergen, Asp f13, which is a serine protease, alkaline protease 1 (Alp 1), promotes airway hyper-responsiveness by infiltrating the bronchial submucosa and disrupting airway smooth muscle (ASM) cell-extracellular matrix (ECM) interactions. Alp 1-mediated ECM degradation evokes pathophysiological RhoA-dependent Ca(2+) sensitivity and bronchoconstriction. These findings support a pathogenic mechanism in asthma and other lung diseases associated with epithelial barrier impairment, whereby ASM cells respond directly to inhaled environmental allergens to generate airway hyper-responsiveness.

Indexed as

Administration, InhalationAllergensAnimalsAspergillus fumigatusAsthmaBacterial ProteinsBronchiBronchoconstrictionCalciumDisease Models, AnimalEndopeptidasesExtracellular MatrixFemaleFungal ProteinsGene ExpressionHistaminealkaline proteaseAllergensBacterial ProteinsCalciumEndopeptidasesFungal ProteinsHistamineImmunoglobulin ErhoA GTP-Binding ProteinRhoA protein, mouserho GTP-Binding Proteins

Identifiers

PMID25865874
PMCPMC4396684
OpenAlexW1988387392

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.